Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEET

v3.2.0.727
CONSOLIDATED BALANCE SHEET - USD ($)
May. 31, 2015
Aug. 31, 2014
Current    
Cash and cash equivalents $ 832,101 $ 703,030
Accounts receivable 21,632 97,003
Inventory 79,344 0
Assets Held For Sale 0 1,400,000
Prepaid expenses and deposit 224,819 367,441
Total Current Assets 1,157,896 2,567,474
Patent 40,955 0
Medical Marijuana Investments 0 67,662
Total Noncurrent Assets 40,955 67,662
TOTAL ASSETS 1,198,851 2,635,136
Current    
Accounts payable and accrued liabilities 60,835 93,553
Loan payable 0 776,936
Share Subscriptions Receivable 0 45,780
Due to a related party 1,769 1,769
Total Current Liabilities 62,604 918,038
TOTAL LIABILITIES 62,604 918,038
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 200,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 39,682,984 common shares at May 31, 2015 and 34,249,690 common shares at August 31, 2014 39,682 34,249
Additional paid-in capital 10,683,185 10,033,438
Shares to be returned (500) (35,200)
Deficit (9,570,059) (8,315,389)
Equity attributable to shareholders of the Company 1,152,308 1,717,098
Non-Controlling Interest (16,061) 0
Total Stockholders' Equity 1,136,247 1,717,098
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 1,198,851 $ 2,635,136